Surgeons withdraw support for heart disease advice

Guidelines recommended both stents and heart surgery for low-risk patients.

But trial data leaked to Newsnight raises sagame doubts about this conclusion.

Thousands of people in the UK and hundreds of thousands worldwide will be treated for left main coronary artery disease each year. This is a narrowing of one of the main arteries in the heart.

The guidelines on how to treat it were largely based on a three-year trial to compare whether heart surgery or stents - a tiny tube inserted into a blocked blood vessel to keep it open - was more effective.

'Check your cholesterol from age 25'
Inequalities in heart attack care 'costing women's lives'
My 'anxiety' was actually a rare heart condition
The trial called Excel started in 2010 and was sponsored by big US stent maker, Abbott.

It was led by eminent US doctor Gregg Stone and aimed to recruit 2,000 patients. Half were given stents and the other half open heart surgery.

Success of the treatments was measured by adding together the number of patients that had heart attacks, strokes, or had died.

The research team used an unusual definition บาคาร่า of a heart attack, but had said that they would also publish data for the more common "Universal" definition of a heart attack alongside it. There is debate around which is a better measure and the investigators stand by their choice.

In 2016, the results of the trial for patients three years after their treatments were published in the prestigious New England Journal of Medicine. The article concluded stents and heart surgery were equally effective for people with left main coronary artery disease.